English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community
Press release submission | Mar 7, 2019

ARIZONA PAIN TREATMENT CENTERS: APTC and Dr. Nasser Help Patients Affected by the Closure of Laser Spine Institute

Press release submission | Feb 27, 2019

INNOVENT BIOLOGICS, INC.: First Patient Dosed in a Clinical Trial of Tyvyt® (Sintilimab injection) in Combination with IBI305 as First Line Treatment for Patients with Advanced Hepatocellular Carcinoma

Press release submission | Feb 27, 2019

KAISER PERMANENTE: Improves Emergency Care for Patients With Chest Pain

Press release submission | Feb 21, 2019

AIVITA BIOMEDICAL, INC.: Completes Treatment of First Patient in Phase 2 Ovarian Cancer Trial

Press release submission | Feb 21, 2019

VRHEALTH: Breast Cancer Patients Cut Hot Flashes and Night Sweats by Half with VR-AI Therapy from VRHealth, Report Finds

Press release submission | Feb 14, 2019

TROVAGENE, INC.: Presents Update on Phase 2 Study of Onvansertib in Combination with Zytiga in Patients with mCRPC at ASCO-GU Conference

Press release submission | Feb 14, 2019

SAVIDA HEALTH: Addiction Medicine Practice Opens 8th Treatment Center in Northern Shenandoah Valley

Press release submission | Feb 7, 2019

MODERNIZING MEDICINE: Dr. Michael Sherling, Chief Medical and Strategy Officer, to Speak with Surescripts at HIMSS about Enabling Price Transparency and Interoperability in Healthcare

Trending

+ Pharmaceuticals
Patient Daily | Jun 18, 2025

ENT specialist on acid reflux: ‘You actually have a structural issue that may predispose you to sinusitis’

+ Pharmaceuticals
Patient Daily | Jun 16, 2025

American Consumer Institute questions hospital use of 340B Drug Pricing Program

+ Pharmaceuticals
Patient Daily | Jun 19, 2025

Patients Come First spokesperson on 340B reform: ‘Americans deserve a system that prioritizes patients first, not pharmacy middlemen’

+ Pharmaceuticals
Patient Daily | Jun 13, 2025

Data scientist: ‘340B sales growth was 115.5% higher than the growth of non-340B sales in 2023’

  • « First
  • «
  • …
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2025 Patient Daily